Sun Pharma Q1 Results : Cons profit falls 20% YoY to Rs 2,278 crore, but revenue rises (...)
Sun Pharma Q1 Results FY26: Sun Pharmaceutical Industries reported a 20% fall in Q1 consolidated net profit, reaching Rs 2,278 crore. Despite this dip, revenue from operations increased by 10% to Rs 13,786 crore. Strong performance in the India market and growth in global innovative medicines (...)
Site référencé: The Economic Times
The Economic Times
India's equity indices fall for fourth consecutive week amid weak earnings
26/07/2025
Dixon’s JV with Chinese firm gets govt nod, other Indian companies may follow
26/07/2025
India ensures safeguards for sensitive sectors in UK FTA
26/07/2025
Donald Trump's Fed tour ends with relief for Jerome Powell
25/07/2025
10 year yield spikes amid a decline in bets on August rate cut
25/07/2025
Hexaware Technologies Q2 Results : Profit jumps 38% YoY to Rs 380 crore but misses estimates
25/07/2025
